echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [Medicine heaven and earth] we have investigated and dealt with pharmacists' certificates in many places. 140 of them are cold! 9 provinces issued documents, focusing on the treatment of Chinese herbal pieces; 5 provinces began to collect 17 kinds of anti-cancer drugs

    [Medicine heaven and earth] we have investigated and dealt with pharmacists' certificates in many places. 140 of them are cold! 9 provinces issued documents, focusing on the treatment of Chinese herbal pieces; 5 provinces began to collect 17 kinds of anti-cancer drugs

    • Last Update: 2018-10-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The local government made a new policy to promote the consistency evaluation of generic drugs in Tianjin On October 10, Tianjin Municipal People's government issued the implementation plan on reforming and improving the supply guarantee and use policy of generic drugs The announcement clearly pointed out that green channels should be set up for the varieties applying for conformity assessment of quality and efficacy of generic drugs, especially those with large clinical use and high proportion of money, so as to speed up the review progress and shorten the working time limit according to their responsibilities Some professionals believe that the introduction of this policy is good for those drugs that are late in the market, but have a huge market share, to pass the consistency evaluation preferentially Hunan Province issued a document, no procurement without conformity evaluation On October 10, Hunan health and Family Planning Commission issued the notice on ensuring the supply of new drugs and varieties through conformity evaluation of quality and efficacy of generic drugs There are three key points in the announcement: (1) if more than three manufacturers of the same kind of drugs pass the consistency evaluation, the varieties that fail to pass the consistency evaluation will no longer be included in the procurement scope of medical institutions; (2) if more than three manufacturers of the same kind of drugs pass the consistency evaluation, the varieties that fail to pass the consistency evaluation will no longer be included in the procurement scope of medical institutions; (3) if they pass the consistency evaluation, the varieties that fail to pass the consistency evaluation will no longer be included in the procurement scope of medical institutions For the consistency evaluation varieties, the online price refers to the average provincial price of the lowest three provinces in China (excluding the provinces adopting the market price mode temporarily) On October 12, the Ministry of human resources and social security of Zhejiang Province issued a notice clearly stipulating that 17 kinds of anticancer drugs negotiated by the state will be included in the scope of class B drugs in the provincial medical insurance catalogue since November 1, 2018 In addition, Guangzhou and Heilongjiang also issued announcements on 17 countries negotiating the purchase of anticancer drugs On October 11, Hubei was the first to issue the notice on doing a good job in the national negotiation on the procurement of 17 anticancer drugs It is pointed out in the announcement that if 17 kinds of anticancer drugs have been put on the Internet in Hubei Province, the price and dynamic adjustment of provincial-level special projects shall be carried out according to the principle of "if they are low, they will not be high", and if they are suspended in the provincial-level special adjustment, their qualification for putting on the Internet will be restored; if 17 kinds of anticancer drugs are not put on the Internet in Hubei Province, they can be put on the Internet according to the requirements of the notice of the provincial health and Family Planning Commission on the Qualification Access of newly listed drugs Enter the qualification access work On the same day, Sichuan issued a notice that the anticancer drugs negotiated for access to the national medical insurance catalog were included in the category of "national negotiated drugs" for centralized online procurement in Sichuan Province, and the direct online procurement was carried out according to the payment standard determined by the state as the purchase price, which was purchased by public hospitals On October 11, Beijing Municipal Food and Drug Administration issued the work plan for strengthening the supervision of Chinese herbal pieces According to the document, the authorities will strictly supervise the production, circulation and use of Chinese herbal medicines, and carry out special sampling work for Chinese herbal pieces, especially for varieties and enterprises with quality risks On the same day, Hunan and Jiangxi provinces also issued the implementation plan for the centralized quality control of Chinese herbal pieces All of them supervise the production, circulation and use of traditional Chinese medicine Hunan proposes to randomly inspect 1000 batches of Chinese herbal pieces, and Jiangxi will increase 350 batches of special supervision and sampling in 2018, in addition to the assigned task On October 10, Heilongjiang Provincial Food and Drug Administration issued the implementation plan for the centralized quality control of Chinese Herbal Pieces in Heilongjiang Province, and decided to carry out a one-year centralized quality control of Chinese Herbal Pieces in the whole province from October 2018 to October 2019 In the aspect of sampling, Heilongjiang will strengthen the inspection of Platycodon, Scutellaria and frankincense In addition to the above-mentioned four provinces, Anhui, Guangxi, Sichuan, Hainan and Jiangsu have issued the centralized regulation documents on Chinese herbal pieces Therefore, it is necessary to pay enough attention to the production enterprises and circulation enterprises of Chinese herbal pieces and carry out self-examination in accordance with relevant regulations On October 12, Shaanxi Provincial Food and Drug Administration issued the newly revised Measures for quality credit rating and classification management of drug manufacturing enterprises in Shaanxi Province There are five key points in the revision: (1) shorten the period of enterprise information evaluation from three years to one year; (2) in the evaluation standard, add quantitative indicators such as defect items found in the inspection; (3) list general defect items and serious defects, main defects and rectification as evaluation indicators, urge the enterprise to correct in time and eliminate risks in the bud; (4) detail To classify the grade of enterprises into AAA, AA and a; (5) to strengthen the application of evaluation results, give priority to supporting trustworthy enterprises, and punish dishonest enterprises On October 12, Chongqing food and Drug Administration issued a notice to recall the GMP certificate of alipiprazole API of Fosun Pharmaceutical subsidiary (Chongqing pharmaceutical industry Research Institute Co., Ltd.), order it to stop production for rectification, and instruct the enterprise to deal with the relevant responsible persons seriously In September, Shaanxi Province recovered 3 GMP sheets, affecting the sales of 47 commonly used drugs On October 9, Shaanxi public resource trading center issued the announcement on the withdrawal / revocation of GMP certificate in September According to the announcement, in September, Shaanxi Provincial Drug Administration recovered the GMP certificates of Guizhou Guangzheng Pharmaceutical Co., Ltd., Hubei lvjin Pharmaceutical Co., Ltd and Tianjin Jinyao group Hubei TIANYAO Pharmaceutical Co., Ltd It is also planned to suspend 20 drug networks of Guizhou Guangzheng Pharmaceutical Co., Ltd and Hubei lvjin Pharmaceutical Co., Ltd., and cancel 27 drug networks of Hubei TIANYAO Pharmaceutical Co., Ltd of Tianjin Jinyao group Since 2018, nearly 900 drug retail enterprises in Dongguan have been accepted into the GSP On October 8, Dongguan drug regulatory bureau of Guangdong Province released two issues of administrative license (cancellation) announcement of drug business license (retail), which showed that 353 drug retail enterprises had been cancelled in total According to relevant media statistics, since 2018, Dongguan drug regulatory bureau has withdrawn / revoked the GSP certificates of 825 drug retail enterprises Since the beginning of the year, nearly 140 licensed pharmacists have been investigated and dealt with by SFDA From January 2018 to now, 140 licensed pharmacists have been investigated and dealt with by SFDA The investigation and punishment are summarized as follows: on October 10, Hubei Provincial Food and drug administration notified Zhang * *, a licensed pharmacist, of his license hanging behavior and dealt with it according to law On September 12, two licensed pharmacists (Li Dongyun and Xia Jingmin) were investigated and punished by Guangdong food and Drug Administration for "certificate hanging" According to relevant media statistics, as of September 13, Guangdong Provincial Drug Administration has notified 43 licensed pharmacists On July 31, Zhenjiang pharmaceutical regulatory bureau of Jiangsu Province issued a circular announcing the "affiliation" of licensed pharmacists and the special rectification of prescription drug sales since March The results showed that 23 licensed pharmacists (519 pharmacies under investigation) had off the job behaviors On July 27, the drug administration of Xinjiang Uygur Autonomous Region issued a notice that one licensed pharmacist cancelled his certificate due to his affiliation On January 19, Shandong Provincial Drug Administration issued a circular announcing 72 licensed pharmacists found in the inspection 8 to carry out the "clearance" action of Licensed Pharmacists On August 7, the people's Government of Yanchuan County, Shaanxi Province announced that it is required to carry out a special inspection on the on-the-job status of licensed pharmacists in retail pharmacies, the registration status of employed licensed pharmacists and the review of prescription drugs by licensed pharmacists from August 1 to September 25, and at the same time, include the allocation and performance of licensed pharmacists in daily supervision On June 7, Liaoning Provincial Drug Administration issued a notice, requiring that pharmacists and pharmacies who are still verified to be "licensed" should be dealt with strictly from August 1, and "licensed" pharmacists should take over their registration certificates, and the GSP certificates should be revoked if they hire "licensed" pharmacies On June 6, Heilongjiang food and Drug Administration issued a notice to carry out the special work of centralized management of "affiliation" of practicing pharmacist qualification certificate The public announcement requires that the licensed licensed pharmacists should collect and cancel their registration certificates If the registration is not accepted within three years and a crime is constituted, their criminal responsibility should be investigated according to law On May 9, Jiangsu Zhenjiang food and Drug Administration issued the credit work plan for drug distribution enterprises and licensed pharmacists, pointing out that if any drug trading enterprise is found to have a license, the Municipal Food and drug administration shall report it to the State Administration of market supervision and administration and revoke its license as an individual licensed pharmacist On May 21, Lanzhou City issued a notice, focusing on the inspection of pharmaceutical technical personnel whether they meet the relevant regulations, whether they are part-time, whether there is "certificate" and whether they have the ability to perform their duties On April 3, Qinghai food and Drug Administration issued a notice to carry out special inspection on outstanding problems of 78 drug wholesale enterprises and 1820 drug retail enterprises in the province, with the focus on the "hang license" behavior of licensed pharmacists On June 29, the drug administration of Lu'an City, Anhui Province issued an announcement As of June 26, 2018, the original licensed pharmacists of 13 pharmaceutical trading enterprises have been cancelled, and no new licensed pharmacists have been employed, and they no longer meet the requirements of pharmaceutical trading conditions The GSP certificate of 13 pharmaceutical trading enterprises has been revoked by the bureau according to law On July 2, Guangdong food and Drug Administration issued a notice that the Licensed Pharmacists of two pharmacies had the act of "hanging the license", which will cancel the GSP certificate of the enterprise according to law and assess their credit rating as "serious dishonesty" Information source: yaozhi.com, drugstore manager, local medicine Station, bureau of health and knowledge, saibelan, local drug administration and other statements: this point of view only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.